Pharmacodynamic effect of continuous vs intermittent dosing of dofetilide on QT interval (Q42779952)

7 November 2017

Pharmacodynamic effect of continuous vs intermittent dosing of dofetilide on QT interval (English)

1 reference

7 November 2017

1 reference

Michael J Allen

1

1 reference

7 November 2017

Stuart D Oliver

series ordinal

2

1 reference

7 November 2017

Margaret W Newgreen

series ordinal

3

1 reference

7 November 2017

Donald J Nichols

series ordinal

4

1 reference

7 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

British Journal of Clinical Pharmacology

7 November 2017

1 reference

7 November 2017

53

1 reference

7 November 2017

1

1 reference

7 November 2017

59-65

1 reference

The pharmacokinetics and pharmacodynamics of oral dofetilide after twice daily and three times daily dosing

7 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874554

Proarrhythmia with class III antiarrhythmic drugs: definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implications

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874554

Comparison of the effects of chronic oral therapy with atenolol and sotalol on ventricular monophasic action potential duration and effective refractory period

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874554

UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874554

A dose-ranging study of UK-68,798, a novel class III anti-arrhythmic agent, in normal volunteers

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874554

Rate and concentration-dependent effects of UK-68,798, a potent new class III antiarrhythmic, on canine Purkinje fibre action potential duration and Vmax

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874554

Dofetilide, a novel class III antiarrhythmic agent

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874554

Voltage- and time-dependent block of the delayed K+ current in cardiac myocytes by dofetilide.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874554

Pharmacokinetic and pharmacodynamic modeling of the effects of oral and intravenous administrations of dofetilide on ventricular repolarization*

27 May 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.0306-5251.2001.01511.X

The Cardiac Arrhythmia Pilot Study. The CAPS investigators

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11849196

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Antiarrhythmic efficacy of a new class III agent, UK-68,798, during chronic myocardial infarction: evaluation using three-dimensional mapping

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11849196

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Acute and chronic effects of sotalol and propranolol on ventricular repolarization using constant-rate pacing

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11849196

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1046/J.0306-5251.2001.01511.X

1 reference

7 November 2017

1 reference

7 November 2017

1 reference